Last reviewed · How we verify

Bupivacain (preoperative)

Başakşehir Çam & Sakura City Hospital · Phase 3 active Small molecule

Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials. Used for Preoperative local and regional anesthesia, Infiltration anesthesia for surgical procedures, Nerve blocks and epidural anesthesia.

At a glance

Generic nameBupivacain (preoperative)
Also known asPreoperative Fascia Iliaca Compartment Block
SponsorBaşakşehir Çam & Sakura City Hospital
Drug classLocal anesthetic (amide class)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 3

Mechanism of action

Bupivacaine reversibly inhibits sodium influx into nerve fibers by binding to sodium channels from the intracellular side, thereby stabilizing the neuronal membrane and preventing depolarization. This results in a loss of sensation in the infiltrated tissue. It is commonly used for regional anesthesia and nerve blocks during surgical procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: